ASX - By Stock
|
HMX |
Re:
Copper Price
|
|
Bmwgsa
|
97 |
28K |
7 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
97
|
28K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Bmwgsa
|
261 |
64K |
16 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Bmwgsa
|
1.3K |
326K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
326K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Bmwgsa
|
323 |
75K |
8 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
75K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
Bmwgsa
|
430 |
107K |
21 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
430
|
107K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Bmwgsa
|
396 |
82K |
9 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Bmwgsa
|
396 |
82K |
7 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Bmwgsa
|
51 |
12K |
16 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
51
|
12K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Bmwgsa
|
147 |
34K |
17 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
147
|
34K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Clinical Trial Update
|
|
Bmwgsa
|
147 |
34K |
7 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
147
|
34K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MPL has anti-cancer effects across multiple cancer types
|
|
Bmwgsa
|
121 |
26K |
9 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
121
|
26K
|
9
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Trading Halt
|
|
Bmwgsa
|
189 |
63K |
3 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
189
|
63K
|
3
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Kalman Resource Upgrade Lifts CuEq Inventory to over 530KT
|
|
Bmwgsa
|
56 |
22K |
10 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
56
|
22K
|
10
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Response to Price Query
|
|
Bmwgsa
|
128 |
39K |
2 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
128
|
39K
|
2
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Response to Price Query
|
|
Bmwgsa
|
128 |
39K |
1 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
128
|
39K
|
1
|
|
ASX - By Stock
|
HMX |
Re:
Ann: Half Year Financial Report
|
|
Bmwgsa
|
5 |
1.8K |
5 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
5
|
1.8K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
Bmwgsa
|
30 |
7.4K |
5 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
30
|
7.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
Bmwgsa
|
30 |
7.4K |
10 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
30
|
7.4K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
Bmwgsa
|
30 |
7.4K |
2 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
30
|
7.4K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
TOP 442 SHAREHOLDERS AS AT 31 AUGUST 2022WITH VARIATIONS
|
|
Bmwgsa
|
30 |
7.4K |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
30
|
7.4K
|
0
|
|